Congo (Dem. Rep.)

BRAVO is a Phased Outbreak-response Study in the DRC Evaluating ERVEBO® Vaccination in ~20,000 Frontline Workers During the 2026 BDV Outbreak, Step A Assesses Real-world Effectiveness, Safety, and Impact on Severe Disease and Mortality, While Generating Evidence for Future BDV Vaccination Strategies

RVF and Other Emerging Infectious Diseases in East and Central Africa

Study of Vaccines Against Bundibugyo Virus Disease in Contacts of Cases in the Democratic Republic of the Congo

Financially-Incentives to Improve Provider Compliance

Testing of a New Rapid Antigen Test for Plague in Ituri, Democratic Republic of the Congo.

Bedside Improvement of Resuscitation Through mHealth Feedback (BIRTH Study)

AI Blind-Sweep Ultrasound for Antenatal Screening by Non-Specialist Health Workers in Rural DR Congo

Mpox Paediatric and Adolescent Clinical Study

Evaluation of Effectiveness and Safety of LC16m8 Mpox Vaccine in the Democratic Republic of Congo (DRC)

Stop Transmission of Gambiense Human African Trypanosomiasis

Low-cost Negative Pressure Wound Therapy vs Standard Dressings for Gustilo IIIb Tibial Fractures (Bukavu Pilot RCT)

Implementation and Evaluation of Vector Control Methods in Kinshasa: The Case of Aedes

Smallpox Vaccine for Mpox Post-Exposure Prophylaxis: A Cluster RCT

A Randomized Clinical Trial Investigating the Safety, Reactogenicity, and Immunogenicity After Immunization With an mRNA-based Mpox Vaccine Candidate in Africa

Surveillance of AMR in DRC

Study to Evaluate the Immunogenicity and Safety of a Heterologous Vaccine Regimen Against Ebola

Prevention of Iron Deficiency Anemia Post-delivery

Realizing Effectiveness Across Continents With Hydroxyurea (REACH)

Caffeine for Hypoxic Ischemic Encephalopathy

Mpox Biology, Outcome, Transmission and Epidemiology - Tracking the Immune Response After mpoX vaCcination (MBOTE-TRAXX): Clinical Study to Monitor the Immunological Response Following Mpox Vaccination in the City of Kinshasa, Democratic Republic of the Congo